OpenAI Introduces ChatGPT Health, Genmab and Anthropic Partner, and Servier's €1B AI Deal

Hi there,

Welcome to the latest edition of Life AI Weekly, where we delve into the transformative world of AI in healthcare and life sciences. This week, we spotlight a range of exciting developments, from OpenAI's introduction of ChatGPT Health, designed to offer personalized health support by integrating user data from wellness apps, to Genmab's collaboration with Anthropic to enhance clinical development processes using AI. These initiatives highlight the growing role of AI in personalizing and optimizing healthcare delivery.

In other news, Servier has teamed up with Iktos to leverage AI for drug discovery, potentially revolutionizing therapeutic development. Meanwhile, the Mount Sinai Tisch Cancer Center has launched the PRISM platform to improve cancer trial access, and Tucuvi has raised $20 million to expand its clinical voice AI capabilities. These stories underscore the diverse applications of AI in advancing medical research and patient care.

OpenAI Introduces ChatGPT Health for Personalized Support

OpenAI has launched ChatGPT Health, a feature aimed at providing personalized health information by connecting user data from wellness apps. The rollout will begin with a limited user group, focusing on privacy and security. Read more

Genmab Partners with Anthropic for AI in Clinical Development

Genmab has partnered with Anthropic to implement Claude-powered AI systems in its clinical development processes. The collaboration aims to enhance data processing, analysis, and document generation while maintaining human oversight. Read more

Servier Partners with Iktos in €1 Billion AI Drug Discovery Deal

French pharmaceutical company Servier has partnered with Iktos to develop new therapies using AI, in a deal potentially exceeding €1 billion. Read more

Mount Sinai Launches AI Platform PRISM for Cancer Trials

The Mount Sinai Tisch Cancer Center has introduced an AI platform called PRISM, developed by Triomics, to enhance access to clinical trials for cancer patients within the Mount Sinai Health System. Read more

Tucuvi Raises $20 Million to Expand AI Technology

Spanish startup Tucuvi has secured $20 million in Series A funding to enhance its clinical voice AI platform and expand operations in Europe and the US. Read more

Boltz Partners with Pfizer and Secures $28M Funding

On January 8, 2026, Boltz announced a partnership with Pfizer to enhance biomolecular AI in drug discovery, alongside securing $28 million in funding to support its initiatives. Read more

Oasys Health Raises $4.6 Million for AI in Behavioral Health

Oasys Health has secured $4.6 million in funding to advance its AI-native operating system for behavioral health. The funding will support platform enhancements, wearable integration, and partnership expansion. Read more

Headlamp Health Introduces Lumos AI for Drug Development

Headlamp Health has launched Lumos AI, a tool aimed at enhancing drug development in neuroscience. Read more

GSK and Noetik Sign $50M AI Licensing Deal for Cancer Research

The partnership between GSK and Noetik involves a five-year collaboration granting GSK access to Noetik's AI models for cancer research, with a $50 million upfront investment. Read more

OpenAI Unveils HIPAA-Compliant ChatGPT for Healthcare

OpenAI has launched a new suite of AI products called ChatGPT for Healthcare, aimed at assisting healthcare organizations while maintaining HIPAA compliance. Major institutions like AdventHealth and Boston Children’s Hospital are already implementing these tools. Read more

Apella Raises $80 Million for AI Health Platform

US-based health technology company Apella has secured $80 million in Series B funding to enhance its AI platform for hospitals, focusing on improving operational efficiency through computer vision and machine learning. Read more

Avista Therapeutics Introduces ARTEMIS AI Platform

Avista Therapeutics has launched ARTEMIS, an AI platform designed to enhance capsid engineering in gene therapy. The platform leverages datasets and machine learning to tackle challenges in AAV capsid design and gene delivery. Read more

FDA Approves Expanded Use of UltraSight AI Software

The FDA has cleared UltraSight to expand its AI-guided platform for use with various ultrasound systems, enhancing the quality of cardiac ultrasound exams. Read more

Brado and Santé Ventures Launch Brado AI

Brado and Santé Ventures have partnered to launch Brado AI, aiming to enhance patient engagement through conversational AI. This initiative seeks to expand Brado's platform to improve healthcare navigation and efficiency. Read more

CytoReason and Sanofi Expand AI Drug Discovery Partnership

On January 9, 2026, CytoReason announced an expanded collaboration with Sanofi in a deal worth up to $16 million, focusing on AI-driven drug discovery. Read more

Cloudforce Secures $10M Series A Funding

Cloudforce, an AI firm, has raised $10 million in Series A funding led by Owl Ventures and Microsoft to expand its AI solutions in education and healthcare. Read more

InvoGenix Launches AI for Healthcare Paperwork

A new AI startup, InvoGenix, founded by University of Illinois students, aims to automate clinical documentation to address the $600 million annual cost of healthcare paperwork in the US. Read more

Utah Allows AI to Renew Prescriptions for Chronic Conditions

Utah has initiated a pilot program using an AI system from Doctronic to renew prescriptions for chronic conditions, excluding those with high abuse potential. The program aims to enhance healthcare access and reduce costs. Read more

Pierre Fabre and Iktos Partner for AI in Oncology Drug Discovery

Pierre Fabre Laboratories and Iktos have announced a collaboration to use AI for drug discovery in oncology. The partnership will leverage Iktos' AI platform and Pierre Fabre's expertise to develop new small-molecule drug candidates. Read more

Aetna Approves Coverage for Cleerly's AI Imaging

Aetna has announced it will cover Cleerly's AI-based cardiovascular imaging analysis, joining other major insurers. This coverage supports AI-QCT technology for coronary artery disease assessment. Read more

Zealand Pharma Partners with DCAI for AI-Driven Drug Discovery

Zealand Pharma has announced a collaboration with DCAI to use the Gefion AI supercomputer to boost their drug discovery initiatives. This partnership is part of their Metabolic Frontier 2030 strategy. Read more

NFL Launches AI Tool for Injury Prediction

The NFL has introduced the Digital Athlete, an AI tool aimed at predicting injuries and improving player health by analyzing data from various activities. Read more

Schrodinger to Integrate Eli Lilly's AI Platform

Schrodinger has announced a collaboration with Eli Lilly to integrate Lilly's AI-based drug discovery platform, TuneLab, into Schrodinger's LiveDesign software. This integration aims to enhance drug development processes by providing access to advanced AI tools. Read more

Genentech Integrates AI in R&D for Drug Development

On January 9, 2026, Genentech announced the integration of AI and ML in its R&D processes to enhance drug discovery and clinical trials. The company is collaborating with AI leaders like NVIDIA to boost its capabilities. Read more

Skylight Health Acquires Stellation Care

Skylight Health has acquired Stellation Care to enhance its AI-driven provider analytics. This move aims to improve their platform with advanced provider intelligence and referral optimization. Read more

FDA Reduces Oversight for AI Clinical Software and Wearables

The FDA has introduced new policies that lower regulatory barriers for AI-enabled clinical decision support software and consumer wearables, allowing them to function under a general wellness framework without strict classification. Read more

Bayer and Cradle Partner for AI in Antibody Discovery

Bayer and Cradle have announced a three-year collaboration to enhance antibody discovery using AI. The partnership aims to improve lead generation and optimization in Bayer's therapeutic antibody pipeline. Read more

Mayo Clinic's AI Tool for Prostate Cancer Education

Researchers at Mayo Clinic have developed MedEduChat, an AI tool integrated with electronic health records to provide personalized education for prostate cancer patients. Read more

Anthropic Launches Claude for Healthcare

Anthropic has introduced Claude for Healthcare, offering HIPAA-compliant tools for healthcare providers, insurers, and consumers. This launch aims to enhance AI integration in medical workflows. Read more

HealthEx and Anthropic Collaborate on Health Insights

HealthEx has partnered with Anthropic to integrate personal health records with the AI assistant Claude, aiming to provide users with actionable health insights from their medical histories. Read more

Google Pulls AI Summaries for Medical Queries

Following an investigation, Google has removed AI-generated overviews for certain health-related searches due to concerns about misleading information. The company aims to improve healthcare search results. Read more

Debiopharm Uses Genialis Software for Biomarker Discovery

Debiopharm has adopted the Genialis Expressions software to improve biomarker discovery and data analytics. This move is part of their ongoing partnership to enhance drug development processes. Read more

Zeya Health Raises $575,000 to Boost AI in Healthcare

Zeya Health, a Singapore-based healthcare technology company, has secured $575,000 in pre-seed funding led by Antler to enhance AI infrastructure for healthcare providers in the Asia-Pacific region. Read more

XtalPi Advances AI-Driven Drug Development with RTX-117

Shenzhen-based AI drug discovery firm XtalPi has achieved a milestone as its incubator company, ReviR Therapeutics, received approval for clinical trials of RTX-117, a drug for Charcot-Marie-Tooth disease. Read more

Israeli Health Ministry Starts AI Regulatory Sandbox

The Israeli Ministry of Health has launched a Regulatory Sandbox program to test AI technologies in healthcare, inviting proposals from companies and organizations. Read more

Owkin Unveils AI Agents for Drug Discovery with Nvidia and Anthropic

Biopharmaceutical AI startup Owkin has launched autonomous AI agents to enhance drug discovery and clinical research, utilizing real patient data from over 800 hospitals globally. Read more

Hippocratic AI Acquires Grove AI to Boost Biopharma AI

Hippocratic AI has acquired Grove AI to enhance its capabilities in biopharma and medtech. The acquisition aims to improve patient engagement and streamline clinical operations. Read more

NVIDIA and Lilly Launch AI Lab for Drug Discovery

NVIDIA and Lilly have announced the establishment of a co-innovation AI lab to advance drug discovery using AI. The initiative involves a $1 billion investment over five years. Read more

Elation Health Integrates Claude AI into EHR

Elation Health has integrated Claude, Anthropic's AI model, into its Electronic Health Record system to enhance clinical insights for primary care. This integration aims to streamline workflows and support decision-making by providing faster, cited chart summaries. Read more

Suvoda Merges with Greenphire, Launches AI Assistant

On January 12, 2026, Suvoda announced its merger with Greenphire and the launch of 'Sofia', an AI assistant aimed at improving clinical trial operations and patient engagement. Read more

Sierra and Stellarus Partner for AI in Healthcare

Sierra and Stellarus have announced a strategic partnership to enhance AI deployment in health plans, integrating Sierra's AI technology into Stellarus's platform. Read more

OpenAI Acquires Healthcare Startup Torch

OpenAI has acquired the healthcare startup Torch for $100 million. The acquisition aims to integrate Torch's technology into OpenAI's ChatGPT Health service. Read more

Converge Bio Secures $25M in Series A Funding

Converge Bio, a startup specializing in generative AI for drug discovery, has raised $25 million in a Series A funding round led by Bessemer Venture Partners. The company has partnerships with 40 firms globally. Read more

Basecamp Research and NVIDIA Launch AI for Gene Insertion

Basecamp Research has partnered with NVIDIA to introduce AI models designed for programmable gene insertion, aiming to advance genetic medicine. Read more

Japan Develops NVIDIA-Powered Robots for Elderly Care

The Japan Science and Technology Agency is creating AI-powered robots, named AIREC, to assist with elderly care using NVIDIA technologies. These robots aim to help with daily tasks to enhance seniors' quality of life. Read more

Knowtex Launches AI Platform at VA Kansas City

On January 13, 2026, Knowtex announced the launch of its AI-powered clinical documentation platform at the VA Kansas City site, marking the start of a national rollout. Read more

Paragon Health Institute Launches AI Initiative for Healthcare

The Paragon Health Institute has introduced a new initiative focused on using artificial intelligence to improve healthcare policies, aiming to reduce costs and enhance patient care. Read more

Thermo Fisher and NVIDIA Collaborate on AI in Biopharma

Thermo Fisher Scientific has partnered with NVIDIA to enhance AI-based solutions and laboratory automation. This collaboration aims to improve the automation, accuracy, and speed of laboratory processes. Read more

Ahead Health Raises €5.1 Million for AI Healthcare Expansion

Ahead Health, a Zurich-based company, has secured €5.1 million to enhance its AI-driven preventive healthcare platform and expand services in Germany, the Netherlands, and Austria. Read more

Illumina Unveils Billion Cell Atlas for AI Drug Discovery

On January 13, 2026, Illumina, Inc. announced the launch of the Billion Cell Atlas, a large-scale genetic dataset designed to enhance AI-driven drug discovery. Developed with partners AstraZeneca, Merck, and Eli Lilly and Company, it aims to map human disease biology by analyzing responses of 1 billion cells to genetic changes. Read more

Categories

Companies

Resources

OpenAI Introduces ChatGPT Health, Genmab and Anthropic Partner, and Servier's €1B AI Deal - Life AI Weekly #50

We hope you enjoyed this article.

More from: Life Sciences

Subscribe to Life AI Weekly